ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,171 | -5.8% | 20,317 | +42.6% | 0.00% | 0.0% |
| Q2 2023 | $147,700 | +87.1% | 14,243 | +45.9% | 0.00% | – |
| Q1 2023 | $78,950 | -48.6% | 9,759 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $153,704 | +30.3% | 9,759 | +30.1% | 0.00% | 0.0% |
| Q3 2022 | $118,000 | +12.4% | 7,501 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $105,000 | -18.6% | 7,501 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $129,000 | +18.3% | 7,501 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $109,000 | +87.9% | 7,501 | +133.6% | 0.00% | – |
| Q3 2021 | $58,000 | +427.3% | 3,211 | +76.6% | 0.00% | – |
| Q1 2019 | $11,000 | -15.4% | 1,818 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -50.0% | 1,818 | 0.0% | 0.00% | – |
| Q3 2018 | $26,000 | -27.8% | 1,818 | 0.0% | 0.00% | – |
| Q2 2018 | $36,000 | +12.5% | 1,818 | 0.0% | 0.00% | – |
| Q1 2018 | $32,000 | -28.9% | 1,818 | 0.0% | 0.00% | – |
| Q4 2017 | $45,000 | +32.4% | 1,818 | +39.7% | 0.00% | – |
| Q3 2017 | $34,000 | -2.9% | 1,301 | 0.0% | 0.00% | – |
| Q2 2017 | $35,000 | -75.5% | 1,301 | -72.9% | 0.00% | -100.0% |
| Q1 2017 | $143,000 | +308.6% | 4,801 | +269.0% | 0.00% | – |
| Q4 2016 | $35,000 | – | 1,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |